Hypertension Treatment with Methyldopa

Initial Dosing Strategy

• The American College of Cardiology recommends starting with 750 mg daily of methyldopa, divided into three doses (250 mg three times a day), with a maximum dose of 4 grams daily divided into 3-4 doses, for hypertension in pregnancy 1
• The initial standard dose is 250 mg three times a day (750 mg/day total) for mild to moderate hypertension (blood pressure 140-169/90-109 mmHg) 1
• The maximum dose is 4000 mg daily, divided into 3-4 doses 1

Treatment Initiation Thresholds

• The European Society of Cardiology recommends initiating treatment at ≥140/90 mmHg in women with gestational hypertension, pre-existing hypertension with superimposed gestational hypertension, or hypertension with subclinical organ damage or symptoms 2, 1
• The European Society of Cardiology also recommends initiating treatment at ≥150/95 mmHg in other circumstances without these risk factors 2, 1

Dose Titration and Monitoring

• The goal of blood pressure is 140-150/90-100 mmHg to balance maternal protection without compromising uteroplacental perfusion 1, 3
• Avoid reducing diastolic blood pressure below 80 mmHg, as it may compromise placental perfusion 1

Clinical Advantages and Safety Profile

• Methyldopa remains a first-line agent due to its extensive safety record without evidence of adverse effects on mothers or babies 1
• Long-term pediatric follow-up data demonstrate safety 1
• Methyldopa has comparable efficacy to labetalol and nifedipine, although it may have more side effects such as drowsiness 3

Critical Warnings

• Discontinue methyldopa immediately after delivery due to the risk of postnatal depression; switch to alternative agents such as ACE inhibitors after delivery 2, 1, 3

Management of Severe Hypertension

• For hypertensive emergencies (blood pressure ≥170/110 mmHg), hospitalization is mandatory 2, 1, 3
• Methyldopa oral may be used alongside or instead of labetalol IV or nifedipine oral for immediate treatment 2, 1

Comparison with Alternatives

• Labetalol has comparable efficacy but may be preferable in patients with headaches, tachycardia, or edema 4, 3
• Both labetalol and nifedipine are compatible with breastfeeding 3
• The American College of Cardiology considers methyldopa a last-line agent for hypertension in non-pregnant adults (250-1000 mg twice daily) due to significant central nervous system side effects, especially in older adults 5